Investor meet intimation
Awaiting price reaction for this filing.
Eris Lifesciences has informed the stock exchanges that its management will participate in the Nuvama Healthcare & Specialty Chemicals Day on Wednesday, June 25, 2025, in an in-person meeting with investor groups. The filing was made on June 16, 2025, to both BSE and NSE under SEBI's Listing Obligations and Disclosure Requirements Regulations. The company has clarified that no unpublished price sensitive information (UPSI) will be shared during the interaction, and only publicly available documents will be referred to. The schedule is described as indicative and subject to change due to unforeseen developments.
This is a routine investor engagement activity and does not signal any material corporate event. Since the company has explicitly stated no UPSI will be discussed, the meeting is unlikely to have a direct impact on stock price, though it provides an opportunity for institutional investors to gain more visibility into Eris Lifesciences' healthcare business.